OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Synergistic potential of immune checkpoint inhibitors and therapeutic cancer vaccines
Mariam Oladejo, Wyatt Paulishak, Laurence M. Wood
Seminars in Cancer Biology (2022) Vol. 88, pp. 81-95
Open Access | Times Cited: 35
Mariam Oladejo, Wyatt Paulishak, Laurence M. Wood
Seminars in Cancer Biology (2022) Vol. 88, pp. 81-95
Open Access | Times Cited: 35
Showing 1-25 of 35 citing articles:
Therapeutic cancer vaccines: advancements, challenges and prospects
Ting Fan, Mingna Zhang, Jingxian Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
Ting Fan, Mingna Zhang, Jingxian Yang, et al.
Signal Transduction and Targeted Therapy (2023) Vol. 8, Iss. 1
Open Access | Times Cited: 195
Advanced Polymeric Nanoparticles for Cancer Immunotherapy: Materials Engineering, Immunotherapeutic Mechanism and Clinical Translation
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 3
Wencong Jia, Ye Wu, Yujie Xie, et al.
Advanced Materials (2025)
Closed Access | Times Cited: 3
Immune Checkpoint Inhibitors Rechallenge in Non-Small Cell Lung Cancer: Current Evidence and Future Directions
Xiaoyu Gang, Jinshan Yan, Xin Li, et al.
Cancer Letters (2024) Vol. 604, pp. 217241-217241
Open Access | Times Cited: 9
Xiaoyu Gang, Jinshan Yan, Xin Li, et al.
Cancer Letters (2024) Vol. 604, pp. 217241-217241
Open Access | Times Cited: 9
Advancements in the application of ablative therapy and its combination with immunotherapy in anti-cancer therapy
Luhong Wang, Yiyi Jiang, Chaoyue Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189285-189285
Closed Access | Times Cited: 1
Luhong Wang, Yiyi Jiang, Chaoyue Sun, et al.
Biochimica et Biophysica Acta (BBA) - Reviews on Cancer (2025) Vol. 1880, Iss. 2, pp. 189285-189285
Closed Access | Times Cited: 1
Cancer vaccines: current status and future directions
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Yi Zhou, Yuquan Wei, Xiaohe Tian, et al.
Journal of Hematology & Oncology (2025) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Living Bacteria: A New Vehicle for Vaccine Delivery in Cancer Immunotherapy
Min Yang, Peiluan Zhong, Pengcheng Wei
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2056-2056
Open Access | Times Cited: 1
Min Yang, Peiluan Zhong, Pengcheng Wei
International Journal of Molecular Sciences (2025) Vol. 26, Iss. 5, pp. 2056-2056
Open Access | Times Cited: 1
Interferon stimulated gene 15 (ISG15) in cancer: An update
Hong-My Nguyen, Shreyas Gaikwad, Mariam Oladejo, et al.
Cancer Letters (2023) Vol. 556, pp. 216080-216080
Open Access | Times Cited: 17
Hong-My Nguyen, Shreyas Gaikwad, Mariam Oladejo, et al.
Cancer Letters (2023) Vol. 556, pp. 216080-216080
Open Access | Times Cited: 17
In Situ Vaccination with An Injectable Nucleic Acid Hydrogel for Synergistic Cancer Immunotherapy
Fujun Wang, Miao Xie, Yangyang Huang, et al.
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 4
Closed Access | Times Cited: 17
Fujun Wang, Miao Xie, Yangyang Huang, et al.
Angewandte Chemie International Edition (2023) Vol. 63, Iss. 4
Closed Access | Times Cited: 17
Current status and future of cancer vaccines: A bibliographic study
Rui Yu, Fangmin Zhao, Zeting Xu, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24404-e24404
Open Access | Times Cited: 7
Rui Yu, Fangmin Zhao, Zeting Xu, et al.
Heliyon (2024) Vol. 10, Iss. 2, pp. e24404-e24404
Open Access | Times Cited: 7
Utility of cell-based vaccines as cancer therapy: Systematic review and meta-analysis
Ankur Tiwari, Karl C. Alcover, Elizabeth L. Carpenter, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Ankur Tiwari, Karl C. Alcover, Elizabeth L. Carpenter, et al.
Human Vaccines & Immunotherapeutics (2024) Vol. 20, Iss. 1
Open Access | Times Cited: 6
Cancer Vaccines in the Immunotherapy Era: Promise and Potential
Chaitenya Verma, Vishakha Anand Pawar, Shivani Srivastava, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1783-1783
Open Access | Times Cited: 13
Chaitenya Verma, Vishakha Anand Pawar, Shivani Srivastava, et al.
Vaccines (2023) Vol. 11, Iss. 12, pp. 1783-1783
Open Access | Times Cited: 13
Emerging advances in delivery systems for mRNA cancer vaccines
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
Zhimei Jiang, Yanhua Xu, Guangsheng Du, et al.
Journal of Controlled Release (2024) Vol. 370, pp. 287-301
Closed Access | Times Cited: 5
Influence of Microbiota on Tumor Immunotherapy
Xin Yu, Wenge Li, Zhi Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2264-2294
Open Access | Times Cited: 4
Xin Yu, Wenge Li, Zhi Li, et al.
International Journal of Biological Sciences (2024) Vol. 20, Iss. 6, pp. 2264-2294
Open Access | Times Cited: 4
Neoantigen architectures define immunogenicity and drive immune evasion of tumors with heterogenous neoantigen expression
Malte Roerden, Andrea Castro, Yufei Cui, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e010249-e010249
Open Access | Times Cited: 4
Malte Roerden, Andrea Castro, Yufei Cui, et al.
Journal for ImmunoTherapy of Cancer (2024) Vol. 12, Iss. 11, pp. e010249-e010249
Open Access | Times Cited: 4
Vaccine-based immunotherapy for pancreatic and colon cancers
Bani Dhother, Mia Rajan, Ananya Kurri, et al.
Elsevier eBooks (2025), pp. 291-303
Closed Access
Bani Dhother, Mia Rajan, Ananya Kurri, et al.
Elsevier eBooks (2025), pp. 291-303
Closed Access
Microneedle-based nanodrugs for tumor immunotherapy
Tianye Wang, Hongyu Liu, Meng Li, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 539-562
Closed Access
Tianye Wang, Hongyu Liu, Meng Li, et al.
Journal of Controlled Release (2025) Vol. 380, pp. 539-562
Closed Access
Nanoparticle-based Traditional Chinese Medicine for Immunotherapy in Gastrointestinal Tumors
Linjia Peng, YanâFeng Liang, Qiuli Zhang, et al.
Nano Biomedicine and Engineering (2025)
Open Access
Linjia Peng, YanâFeng Liang, Qiuli Zhang, et al.
Nano Biomedicine and Engineering (2025)
Open Access
Alginate sulfated polysaccharide TGC161 exhibits antitumor activity via suppression of STING activation-mediated T-cell apoptosis
Chuanqin Shi, Yu Long Han, Lingwen Gu, et al.
Carbohydrate Polymer Technologies and Applications (2025), pp. 100759-100759
Open Access
Chuanqin Shi, Yu Long Han, Lingwen Gu, et al.
Carbohydrate Polymer Technologies and Applications (2025), pp. 100759-100759
Open Access
Cancer Nanovaccines: Mechanisms, Design Principles, and Clinical Translation
Gabriel de Camargo Zaccariotto, Maria Julia Bistaffa, Angelica Maria Mazuera Zapata, et al.
ACS Nano (2025)
Open Access
Gabriel de Camargo Zaccariotto, Maria Julia Bistaffa, Angelica Maria Mazuera Zapata, et al.
ACS Nano (2025)
Open Access
Advances in Therapeutic Cancer Vaccines, Their Obstacles, and Prospects Toward Tumor Immunotherapy
Azadeh Eskandari, Thean Chor Leow, Mohd Basyaruddin Abdul Rahman, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
Azadeh Eskandari, Thean Chor Leow, Mohd Basyaruddin Abdul Rahman, et al.
Molecular Biotechnology (2024)
Closed Access | Times Cited: 3
CD105 in the progression and therapy of renal cell carcinoma
Mariam Oladejo, Hong-My Nguyen, Laurence M. Wood
Cancer Letters (2023) Vol. 570, pp. 216327-216327
Closed Access | Times Cited: 8
Mariam Oladejo, Hong-My Nguyen, Laurence M. Wood
Cancer Letters (2023) Vol. 570, pp. 216327-216327
Closed Access | Times Cited: 8
Mechanism of action and treatment of type I interferon in hepatocellular carcinoma
Chunxiu Peng, Zhijian Ye, Ying Ju, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 2, pp. 326-337
Closed Access | Times Cited: 7
Chunxiu Peng, Zhijian Ye, Ying Ju, et al.
Clinical & Translational Oncology (2023) Vol. 26, Iss. 2, pp. 326-337
Closed Access | Times Cited: 7
Knowledge mapping of therapeutic cancer vaccine from 2013 to 2022: A bibliometric and visual analysis
Juan Zhao, Bin Liao, Li Gong, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
Juan Zhao, Bin Liao, Li Gong, et al.
Human Vaccines & Immunotherapeutics (2023) Vol. 19, Iss. 2
Open Access | Times Cited: 4
Adjuvants in cutaneous vaccination: A comprehensive analysis
Mariam Oladejo, Akeemat O. Tijani, Ashana Puri, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 475-492
Closed Access | Times Cited: 1
Mariam Oladejo, Akeemat O. Tijani, Ashana Puri, et al.
Journal of Controlled Release (2024) Vol. 369, pp. 475-492
Closed Access | Times Cited: 1
In Situ Vaccination with An Injectable Nucleic Acid Hydrogel for Synergistic Cancer Immunotherapy
Fujun Wang, Miao Xie, Yangyang Huang, et al.
Angewandte Chemie (2023) Vol. 136, Iss. 4
Closed Access | Times Cited: 2
Fujun Wang, Miao Xie, Yangyang Huang, et al.
Angewandte Chemie (2023) Vol. 136, Iss. 4
Closed Access | Times Cited: 2
